What is the initial management for esophageal spasm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Management of Esophageal Spasm

Start with proton pump inhibitors (PPIs) as first-line therapy, particularly when symptoms overlap with GERD, followed by smooth muscle relaxants or neuromodulators if symptoms persist. 1

Immediate Diagnostic Steps

Before initiating treatment, perform upper GI endoscopy to exclude structural abnormalities, malignancy, and eosinophilic esophagitis, which can mimic esophageal spasm but requires entirely different management. 1 High-resolution manometry (HRM) is essential for accurate diagnosis and classification of the motility disorder before committing to specific therapies. 1

First-Line Pharmacological Approach

PPIs as Initial Therapy

  • Begin with PPIs regardless of whether reflux symptoms are prominent, as GERD frequently coexists with esophageal spasm and untreated reflux will undermine all other therapeutic efforts. 1, 2, 3
  • This is particularly critical since esophageal spasm associated with reflux responds poorly to smooth muscle relaxants alone. 3

Smooth Muscle Relaxants (Second Step)

If symptoms persist after adequate PPI trial:

  • Nitrates (sublingual nitroglycerin or long-acting nitrites) are highly effective for diffuse esophageal spasm without reflux, with sustained symptom control documented for 6 months to 4 years. 3
  • Calcium channel blockers like diltiazem (60 mg three times daily) may provide relief in selected individual patients, though overall efficacy is inconsistent. 4
  • The American Gastroenterological Association endorses smooth muscle relaxants as effective treatment approaches. 1

Neuromodulators (Third Step)

  • Antidepressants can be beneficial for esophageal spasm, particularly when there is associated hypervigilance or hypersensitivity. 1, 2
  • Baclofen may help with regurgitation and belch-predominant symptoms, though CNS and GI side effects limit tolerability. 1

Critical Pitfall to Avoid

Never use metoclopramide for esophageal spasm—the American Gastroenterological Association explicitly recommends against it due to evidence that harms outweigh benefits. 1

Endoscopic Intervention for Persistent Symptoms

Botulinum toxin injection is the best-studied treatment option for refractory esophageal spasm, with 78-89% of patients achieving remission after a single injection session. 5, 6 The technique involves:

  • Injecting 100 IU botulinum toxin diluted in 10 mL saline at multiple sites along the esophageal wall
  • Starting at the lower esophageal sphincter and moving proximally in 1-1.5 cm intervals
  • Targeting any visible contraction rings 6
  • Symptom relief lasts 8-24 months, and reinjection is effective for recurrence. 6

Surgical Options for Refractory Cases

Per-oral endoscopic myotomy (POEM) is the preferred surgical treatment for type III achalasia and may benefit select cases of distal esophageal spasm refractory to all other therapies. 1 Traditional surgical myotomy should be reserved for patients with very severe symptoms who have failed pharmacologic and endoscopic treatments. 5

Adjunctive Behavioral Interventions

Cognitive behavioral therapy, esophageal-directed hypnotherapy, and diaphragmatic breathing can be effective when hypervigilance or hypersensitivity contributes to symptoms. 1

References

Guideline

Treatment Options for Esophageal Spasms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Esophageal dysphagia].

Therapeutische Umschau. Revue therapeutique, 2007

Research

Efficacy of diltiazem in the treatment of diffuse oesophageal spasm.

Alimentary pharmacology & therapeutics, 1990

Research

Botulinum toxin in the treatment of diffuse esophageal spasm.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.